💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Repros Therapeutics Inc. (RPRX)
« Back to company indexRPRX Chatter Timeline
Stock Ticker for RPRX
Most Active Tweeters for RPRX
| User | Tweets |
|---|---|
| @deus_trader | 6 |
| @stock_titan | 4 |
| @otcdynamics | 4 |
| @FlashAlert_me | 3 |
| @sbwcws | 2 |
Recent Tweets for RPRX
 |
@intratio $RPRX https://t.co/yVzsFgz4Yx Royalty Pharma Plc The model concludes this company s stock price has a neutral short… https://t.co/LqqvddDsM7 7:10pm |
 |
@deus_trader Optimus v4 2020-10-19 14:05 ET. Bought/Opened: $RPRX at $40.99. Royalty Pharma plc (CORP). Win Chance: 72%. Avg Wi… https://t.co/swYSSojj0P 2:10pm |
 |
@YuMiStockTrade https://t.co/v6MD2eZBM5 $RPRX Moving 1:10pm |
|
@deus_trader Optimus v4 2020-10-19 10:45 ET. *Closed/Sold: $RPRX at $42.48 for 0.07 profit (0.17%). Royalty Pharma plc (CORP). T… https://t.co/NHcNARhWMB 10:10am |
 |
@otcdynamics $RPRX Royalty Pharma to Announce Third-Quarter 2020 Financial Results on November 11, 2020 https://t.co/OVoivbQPmU 9:10am |
 |
@HottestStockNow Upcoming Key Date for $RPRX Shareholders #RoyaltyPharma https://t.co/t3BshL1aoX 9:10am |
 |
@stock_titan $RPRX Royalty Pharma to Announce Third-Quarter 2020 Financial Results on November 11, 2020 https://t.co/qo6dbxy9Co 9:10am |
 |
@ChartMill $RPRX was analyzed by 7 analysts. The buy consensus is at 71%. So analysts seem to be mildly confident about $RPRX.… https://t.co/DtEE9WZmhh October 18th 2020, 11:10am |
 |
@TranscriptDaily Royalty Pharma $RPRX Lowered to Hold at Zacks Investment Research https://t.co/VmVO92R1fo October 18th 2020, 7:10am |
 |
@ZolmaxNews Royalty Pharma PLC $RPRX Declares Quarterly Dividend of $0.15 https://t.co/GhDciadm6U October 17th 2020, 7:10am |
 |
@dispatchtribune Royalty Pharma PLC $RPRX Declares Quarterly Dividend of $0.15 https://t.co/ay5oeccWQ6 October 17th 2020, 7:10am |
 |
@stocknewstimes Zacks Investment Research Lowers Royalty Pharma $RPRX to Hold https://t.co/jyjXEwbgXc October 17th 2020, 6:10am |
 |
@TheMarketsDaily Zacks Investment Research Lowers Royalty Pharma $RPRX to Hold https://t.co/nV87K0ynq8 October 17th 2020, 6:10am |
 |
@hodlonion Trimmed more $SPCE & added more to my $RPRX still got 31% of my Bag in @virgingalactic might trim more & looking to long the rest.. October 16th 2020, 1:10pm |
 |
@SusanBrust1 @MatthewMcCall any thoughts on $RPRX and $RXT? October 16th 2020, 12:10pm |
 |
@Gambiste1 RT @FoonerJ: Even with new share offering, I still expect $RPRX to deliver 8-10% share price growth + dividends over the next 5 years. October 16th 2020, 11:10am |
 |
@mehabecapital (Heavy Volumes at 10x normal) $RPRX(Royalty Pharma plc) trading at $42.16, change today = 0.79% https://t.co/GN49GMU6Nz October 16th 2020, 11:10am |
|
@deus_trader Optimus v4 2020-10-16 11:30 ET. Bought/Opened: $RPRX at $42.38. Royalty Pharma plc (CORP). Win Chance: 70%. Avg Wi… https://t.co/XC2xQXTrcO October 16th 2020, 11:10am |
 |
@FoonerJ Even with new share offering, I still expect $RPRX to deliver 8-10% share price growth + dividends over the next 5 years. October 16th 2020, 9:10am |
|
@YuMiStockTrade https://t.co/XpWeCsvv2o $BAC, $RPRX Moving October 16th 2020, 9:10am |
 |
@WatchlistN Royalty Pharma $RPRX Stock Rating Lowered by Zacks Investment Research https://t.co/CCN82ZW66v October 16th 2020, 8:10am |
 |
@TickerReport Royalty Pharma $RPRX Stock Rating Lowered by Zacks Investment Research https://t.co/Lm96hBtHC4 October 16th 2020, 7:10am |
 |
@dailypoliticaln Royalty Pharma $RPRX Stock Rating Lowered by Zacks Investment Research https://t.co/UKmkxC1ttH October 16th 2020, 7:10am |
 |
@ThisLincolnian Royalty Pharma $RPRX Stock Rating Lowered by Zacks Investment Research https://t.co/8dWMdCsp9o October 16th 2020, 7:10am |
 |
@Briefingcom $RPRX: Royalty Pharma prices secondary offering of 17,343,037 shares of its Class A ordinary shares by selling... https://t.co/CqSyuw7stw October 16th 2020, 6:10am |
 |
@sbwcws Royalty Pharma 17.3M share Secondary priced at $42.00 $RPRX October 16th 2020, 6:10am |
 |
@MarketCurrents $RPRX - Royalty Pharma prices secondary offering of shares https://t.co/tz15OLaHsR October 16th 2020, 6:10am |
|
@otcdynamics $RPRX Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders https://t.co/N51lhzbKSh October 15th 2020, 11:10pm |
 |
@FlashAlert_me $RPRX [15s. delayed]: Issued Press Release on October 15, 23:45:00: Royalty Pharma Announces Pricing of Secondary O… https://t.co/h7tlnAGN6V October 15th 2020, 11:10pm |
|
@stock_titan $RPRX Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders… https://t.co/5WCaMBgw8W October 15th 2020, 11:10pm |
|
@otcdynamics $RPRX Royalty Pharma Declares Fourth-Quarter 2020 Dividend https://t.co/C0ZWQJ6ZQ4 October 15th 2020, 9:10am |
|
@FlashAlert_me $RPRX [15s. delayed]: Issued Press Release on October 15, 09:15:00: Royalty Pharma Declares Fourth-Quarter 2020 Div… https://t.co/kMHbaAtCvZ October 15th 2020, 9:10am |
|
@stock_titan $RPRX Royalty Pharma Declares Fourth-Quarter 2020 Dividend https://t.co/dyzFJ1ezvA #dividends October 15th 2020, 9:10am |
|
@ZolmaxNews Royalty Pharma $RPRX Cut to “Hold” at Zacks Investment Research https://t.co/n8wLqI3XAF October 15th 2020, 7:10am |
|
@dispatchtribune Royalty Pharma $RPRX Downgraded by Zacks Investment Research to “Hold” https://t.co/hv29GtGJGa October 15th 2020, 7:10am |
 |
@RealPeaceUSA @jimcramer $rprx is planning to sell 17.3 million shares. Is this a good time to get in after the announcement? October 14th 2020, 10:10am |
 |
@OlympiaReport Royalty Pharma $RPRX Downgraded by Zacks Investment Research https://t.co/ryWT4QBGH8 October 14th 2020, 10:10am |
|
@dakotafinancial Royalty Pharma $RPRX Downgraded by Zacks Investment Research https://t.co/bl8Zd23V09 October 14th 2020, 10:10am |
 |
@BluedeerC Short $RPRX 44.25 here is the read: RPRX-- Unless you can sell RPRX as close to 44.00 as possible, enabling you to… https://t.co/j2YnsEm07k October 14th 2020, 9:10am |
 |
@EmilioVastola $RPRX nice sideways action, potential starter above $45 https://t.co/XbSlf0RAfj https://t.co/3UeVV8OuFi October 13th 2020, 11:10pm |
 |
@newsfilterio Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders $RPRX https://t.co/UgDxmyoGol October 13th 2020, 8:10pm |
|
@newsfilterio Royalty Pharma under pressure post secondary offering of shares $RPRX https://t.co/yO1HcesXXE October 13th 2020, 7:10pm |
 |
@X7F4REuMYxqu6Lz Royalty Pharma under pressure post secondary offering of shares ?$RPRX 17.3M of the company's Class A ordinary sha… https://t.co/kA9kGnIGWL October 13th 2020, 6:10pm |
|
@Briefingcom $RPRX: Royalty Pharma files for 17,343,037 Class A ordinary share offering by selling shareholders https://t.co/qEboBumw3o October 13th 2020, 6:10pm |
|
@otcdynamics $RPRX Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders https://t.co/EflVdWgHtv October 13th 2020, 4:10pm |
 |
@portefeuillefun RT @MSollender: $RPRX Royalty Pharma Announces Secondary Offering of Class A Ordinary Shares by Selling Shareholders 17,343,037 of the Com… October 13th 2020, 4:10pm |
 |
@_B_I_O_T_E_C_H_ $RPRX ROYALTY PHARMA SAYS SELLING SHAREHOLDERS ARE OFFERING 17.3 MLN CLASS A ORDINARY SHARES UNDER THE PROSPECTUS - SEC FILING October 13th 2020, 4:10pm |
|
@sbwcws Royalty Pharma files to sell 17.3M shares of Class A Ordinary shares for holders $RPRX October 13th 2020, 4:10pm |
 |
@pnani456 RT @TraderTexMex: $RPRX offering October 13th 2020, 4:10pm |
|
@FlashAlert_me $RPRX [15s. delayed]: Issued Press Release on October 13, 16:10:00: Royalty Pharma Announces Secondary Offering of… https://t.co/lgA86ed7yX October 13th 2020, 4:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
